Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Pulse 2.0
pulse2.com > system-raises-20-million

System Raises $20 Million To Build Vertically Integrated Peptide Platform As Market Reaches $163 Billion

4+ day, 23+ hour ago   (222+ words) System is positioning itself around a category that has expanded beyond its early association with niche biohacking communities. The company cited estimates placing the global peptide therapeutics market at approximately $140 billion in 2025 and $163 billion in 2026. System also sees a changing…...

Pulse 2.0
pulse2.com > eis-adds-environmental-construction-to-expand-florida-demolition-and-remediation-capabilities

EIS Adds Environmental Construction To Expand Florida Demolition And Remediation Capabilities

1+ week, 5+ day ago   (258+ words) Pulse 2.0 EIS Holdings recently expanded its operational footprint in Florida by acquiring Environmental Construction, LLC, a renowned Tampa-based firm specializing in commercial demolition, abatement, and comprehensive environmental remediation services. This strategic transaction significantly enhances EIS’ capacity to self-perform a range…...

Google News
pulse2.com > cp-capital-acquires-200-unit-ascent-athens-at-95-occupancy-as-firm-targets-assets-below-replacement-cost

CP Capital Acquires 200-Unit Ascent Athens At 95% Occupancy As Firm Targets Assets Below Replacement Cost

2+ week, 1+ day ago   (284+ words) CP Capital has acquired Ascent Athens, a 200-unit Class A multifamily community in Athens, Georgia, as the investment manager targets high-quality apartment properties available below replacement cost. Ascent Athens is currently 95% occupied and was developed by Westplan in 2020. The garden-style…...

Pulse 2.0
pulse2.com > sunshine-biopharma-cash-rises-51-to-13-7-million-while-inventory-falls-to-12-1-million

Sunshine Biopharma: Cash Rises 51% To $13.7 Million While Inventory Falls To $12.1 Million

3+ week, 5+ day ago   (428+ words) Sunshine Biopharma increased its cash and cash equivalents by approximately 51% during the first half of 2026 to $13.75 million, up from $9.12 million at the end of 2025, while net inventory declined to $12.12 million from $13.47 million. The stronger cash position was supported primarily by…...